The Strepsils range comprises therapeutic devices designed for the symptomatic relief of mild sore throats without associated fever, and for the local treatment of superficial oral affections such as mouth ulcers or small mucous membrane lesions. It is mainly based on a galenic form of lozenges to be sucked, with a local and progressive action, as well as on a collutory liquid form intended for direct application to the inflamed area.
Distributed by the Reckitt Benckiser group, the Strepsils brand benefits from the pharmaceutical expertise acquired since the integration of Boots Healthcare in 2006. Today, Strepsils is one of the major references in the OTC sore throat segment.
Strepsils specialties are indicated for the local treatment of benign throat ailments, whether infectious (viral pharyngitis), inflammatory (mucous membrane irritation), environmental (pollutants, dry air) or mechanical (vocal overuse, repeated coughing) in origin. Some formulations are also effective against mouth ulcers and small, non-superinfected mouth sores.
Targeted symptoms include:
Strepsils lozenges contain a combination of two local antiseptics:
These substances have broad-spectrum antimicrobial activity against common pathogens of the oropharyngeal tract. Their combined action is designed to limit local bacterial proliferation, thereby reducing inflammation and irritation.
The lozenge dosage form enables prolonged release of the active ingredients, optimizing their contact with the mucous membranes of the mouth and throat.
For patients with moderate to severe pharyngeal pain, particularly in cases of significant swallowing discomfort, the range offers reinforced formulations containing lidocaine.
These formulations are reserved for adults and children over 12 years of age, due to the risk of misdirection associated with local anesthesia of the throat. Their use is contraindicated around meals.
To ensure better compliance, the range offers several flavors:
Strepsils Classic lozenges can be administered to children aged 6 and over, under supervision. Each lozenge should be sucked slowly, without chewing, to ensure prolonged contact with the buccopharyngeal mucosa and optimize therapeutic efficacy.
Strepsils is the benchmark therapeutic solution for the symptomatic management of uncomplicated sore throats. Thanks to its dual antiseptic formulation, varied formats (lozenges and spray), multiple flavors and accessibility from age 6, the brand covers a wide spectrum of needs.
Lidocaine-enriched versions provide additional relief for more intense pain, mouth ulcers and small mouth sores. The entire range is designed for localized, practical and well-tolerated self-medication, provided the precautions for use and indications are respected.
